ATYR PHARMA INC 宣布安排与美国FDA进行C类会议,讨论Efzofitimod治疗肺结节病项目

美股速递
Feb 03

ATYR PHARMA INC 已正式安排与美国食品药品监督管理局(FDA)举行C类会议,重点讨论其候选药物Efzofitimod在肺结节病领域的研发项目。此次会议旨在就该项目的关键开发路径与监管机构进行深入交流。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10